Literature DB >> 22926323

High throughput measurement of Ca²⁺ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry.

Fabio Cerignoli1, David Charlot, Ross Whittaker, Randy Ingermanson, Piyush Gehalot, Alex Savchenko, David J Gallacher, Rob Towart, Jeffrey H Price, Patrick M McDonough, Mark Mercola.   

Abstract

Current methods to measure physiological properties of cardiomyocytes and predict fatal arrhythmias that can cause sudden death, such as Torsade de Pointes, lack either the automation and throughput needed for early-stage drug discovery and/or have poor predictive value. To increase throughput and predictive power of in vitro assays, we developed kinetic imaging cytometry (KIC) for automated cell-by-cell analyses via intracellular fluorescence Ca²⁺ indicators. The KIC instrument simultaneously records and analyzes intracellular calcium concentration [Ca²⁺](i) at 30-ms resolution from hundreds of individual cells/well of 96-well plates in seconds, providing kinetic details not previously possible with well averaging technologies such as plate readers. Analyses of human embryonic stem cell and induced pluripotent stem cell-derived cardiomyocytes revealed effects of known cardiotoxic and arrhythmogenic drugs on kinetic parameters of Ca²⁺ dynamics, suggesting that KIC will aid in the assessment of cardiotoxic risk and in the elucidation of pathogenic mechanisms of heart disease associated with drugs treatment and/or genetic background.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926323      PMCID: PMC3667588          DOI: 10.1016/j.vascn.2012.08.167

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  52 in total

1.  The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block.

Authors:  Ruth L Martin; Jeff S McDermott; Heinz J Salmen; Jason Palmatier; Bryan F Cox; Gary A Gintant
Journal:  J Cardiovasc Pharmacol       Date:  2004-03       Impact factor: 3.105

Review 2.  Dynamic control of hERG/I(Kr) by PKA-mediated interactions with 14-3-3.

Authors:  Anna Kagan; Thomas V McDonald
Journal:  Novartis Found Symp       Date:  2005

3.  Analyzing proteome topology and function by automated multidimensional fluorescence microscopy.

Authors:  Walter Schubert; Bernd Bonnekoh; Ansgar J Pommer; Lars Philipsen; Raik Böckelmann; Yanina Malykh; Harald Gollnick; Manuela Friedenberger; Marcus Bode; Andreas W M Dress
Journal:  Nat Biotechnol       Date:  2006-10-01       Impact factor: 54.908

4.  Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration.

Authors:  L Patmore; S Fraser; D Mair; A Templeton
Journal:  Eur J Pharmacol       Date:  2000-10-20       Impact factor: 4.432

5.  Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).

Authors:  Rie Schultz Hansen; Thomas Goldin Diness; Torsten Christ; Joachim Demnitz; Ursula Ravens; Søren-Peter Olesen; Morten Grunnet
Journal:  Mol Pharmacol       Date:  2005-10-11       Impact factor: 4.436

Review 6.  ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis.

Authors:  Icilio Cavero; William Crumb
Journal:  Expert Opin Drug Saf       Date:  2005-05       Impact factor: 4.250

7.  Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.

Authors:  S Zhang; Z Zhou; Q Gong; J C Makielski; C T January
Journal:  Circ Res       Date:  1999-05-14       Impact factor: 17.367

8.  Differential effects of phospholamban and Ca2+/calmodulin-dependent kinase II on [Ca2+]i transients in cardiac myocytes at physiological stimulation frequencies.

Authors:  Andreas A Werdich; Eduardo A Lima; Igor Dzhura; Madhu V Singh; Jingdong Li; Mark E Anderson; Franz J Baudenbacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

Review 9.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

10.  Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.

Authors:  L E Solem; T R Henry; K B Wallace
Journal:  Toxicol Appl Pharmacol       Date:  1994-12       Impact factor: 4.219

View more
  37 in total

Review 1.  The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.

Authors:  Lingqun Ye; Xuan Ni; Zhen-Ao Zhao; Wei Lei; Shijun Hu
Journal:  J Cardiovasc Transl Res       Date:  2018-05-29       Impact factor: 4.132

2.  A phenotypic in vitro model for the main determinants of human whole heart function.

Authors:  Maria Stancescu; Peter Molnar; Christopher W McAleer; William McLamb; Christopher J Long; Carlota Oleaga; Jean-Matthieu Prot; James J Hickman
Journal:  Biomaterials       Date:  2015-05-14       Impact factor: 12.479

3.  Pluripotent stem cells as a platform for cardiac arrhythmia drug screening.

Authors:  Jordan S Leyton-Mange; David J Milan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

4.  L-type Ca2+ channel responses to bay k 8644 in stem cell-derived cardiomyocytes are unusually dependent on holding potential and charge carrier.

Authors:  Junzhi Ji; Jiesheng Kang; David Rampe
Journal:  Assay Drug Dev Technol       Date:  2014-08       Impact factor: 1.738

Review 5.  Screening out irrelevant cell-based models of disease.

Authors:  Peter Horvath; Nathalie Aulner; Marc Bickle; Anthony M Davies; Elaine Del Nery; Daniel Ebner; Maria C Montoya; Päivi Östling; Vilja Pietiäinen; Leo S Price; Spencer L Shorte; Gerardo Turcatti; Carina von Schantz; Neil O Carragher
Journal:  Nat Rev Drug Discov       Date:  2016-09-12       Impact factor: 84.694

6.  Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.

Authors:  Jose Francisco Islas; Yu Liu; Kuo-Chan Weng; Matthew J Robertson; Shuxing Zhang; Allan Prejusa; John Harger; Dariya Tikhomirova; Mani Chopra; Dinakar Iyer; Mark Mercola; Robert G Oshima; James T Willerson; Vladimir N Potaman; Robert J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

7.  Assay of Calcium Transients and Synapses in Rat Hippocampal Neurons by Kinetic Image Cytometry and High-Content Analysis: An In Vitro Model System for Postchemotherapy Cognitive Impairment.

Authors:  Patrick M McDonough; Natalie L Prigozhina; Ranor C B Basa; Jeffrey H Price
Journal:  Assay Drug Dev Technol       Date:  2017-07       Impact factor: 1.738

8.  Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity.

Authors:  Oksana Sirenko; Evan F Cromwell; Carole Crittenden; Jessica A Wignall; Fred A Wright; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-01       Impact factor: 4.219

Review 9.  Induced pluripotent stem cells in cardiovascular drug discovery.

Authors:  Mark Mercola; Alexandre Colas; Erik Willems
Journal:  Circ Res       Date:  2013-02-01       Impact factor: 17.367

Review 10.  Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?

Authors:  Arne An Bruyneel; Wesley L McKeithan; Dries Am Feyen; Mark Mercola
Journal:  Curr Opin Pharmacol       Date:  2018-08-03       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.